Japan withdraws 1.6 mln Moderna COVID-19 vaccine doses over contamination - Nikkei

United States News News

Japan withdraws 1.6 mln Moderna COVID-19 vaccine doses over contamination - Nikkei
United States Latest News,United States Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

Around 1.6 million doses of Moderna Inc's COVID-19 vaccine has been withdrawn from use in Japan due to contamination, the Nikkei said, citing a health ministry announcement on Thursday.

Several vaccination centres reported vials contained "foreign matter", the report said, adding that the ministry will look to minimise the impact of the withdrawal on Japan's vaccination drive.

Both Moderna and Takeda did not immediately respond to Reuters requests for comment.More from ReutersSubscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Japan to further expand virus emergency areas as Covid cases surgeJapan to further expand virus emergency areas as Covid cases surgeJapan plan to expand its coronavirus state of emergency for a second week in a row amid surge in Delta variant strain testing its healthcare system
Read more »

Japan to further expand virus emergency areas as cases surgeJapan to further expand virus emergency areas as cases surgeTOKYO (AP) — Japan was set to expand its coronavirus state of emergency for a second week in a row Wednesday, adding several more prefectures as a surge in infections fueled by the delta variant strains the country's health care system.
Read more »

Moderna completes submission to FDA for full approval of its Covid-19 vaccineModerna completes submission to FDA for full approval of its Covid-19 vaccineModerna announced on Wednesday it has completed its submission to the US Food and Drug Administration for full approval of its Covid-19 vaccine for people age 18 and older.
Read more »



Render Time: 2025-02-25 13:36:49